• Explore /
  • Poster
  • / A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity.

A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity.

Abstract Poster

Authors

null

Benedict J. Panizza

Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia

Benedict J. Panizza , Stephen John O'Leary , Christopher David Hart , Chandra Sai Diwakarla , Catherine Barnett , Pablo Lapuerta , John Lee , Shane Raines , Tera Quigley , Heather M Wolff , John Keilty , Rahul Ladwa , Sandro V Porceddu , Margaret McGrath , Nagashree Seetharamu , Tsien Fua , Danny Rischin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Other Head and Neck Cancer (Salivary, Thyroid)

Clinical Trial Registration Number

NCT04262336

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 6100)

DOI

10.1200/JCO.2024.42.16_suppl.6100

Abstract #

6100

Poster Bd #

416

Abstract Disclosures

Similar Posters

First Author: Danny Rischin

First Author: Eric S. Winer

First Author: Sun Young Rha

Poster

2023 ASCO Annual Meeting

Safety and efficacy of cannabidiol in the management of chemotherapy-induced peripheral neuropathy.

Safety and efficacy of cannabidiol in the management of chemotherapy-induced peripheral neuropathy.

First Author: Marisa C. Weiss